ALFACELL CORPORATION AMENDMENT TO SECURITIES PURCHASE AGREEMENT February 26, 2010Securities Purchase Agreement • March 4th, 2010 • Alfacell Corp • Biological products, (no disgnostic substances) • New York
This Amendment (this “Amendment”) to that certain Securities Purchase Agreement dated as of October 19, 2009 (the “Agreement”) by and among Alfacell Corporation, a Delaware corporation (the “Company”) and the investors identified on the signature pages thereto (the “Purchasers”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Agreement.
ALFACELL CORPORATION AMENDMENT TO EACH 5% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE February 26, 2010Alfacell Corp • March 4th, 2010 • Biological products, (no disgnostic substances) • New York
This Amendment (this “Amendment”) to each 5% Senior Secured Convertible Promissory Note (each a “Note” and collectively, the “Notes”) issued by Alfacell Corporation, a Delaware corporation (the “Company”) pursuant to that certain Securities Purchase Agreement dated as of October 19, 2009, to the holders thereof (collectively, the “Holders”), is made and entered into as of February 26, 2010, by and among the Company and the Holders. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Notes.
ALFACELL CORPORATION AMENDMENT TO INVESTOR RIGHTS AGREEMENT February 26, 2010Investor Rights Agreement • March 4th, 2010 • Alfacell Corp • Biological products, (no disgnostic substances) • New York
This Amendment (this “Amendment”) to that certain Investor Rights Agreement dated as of October 19, 2009 (the “Agreement”) by and among Alfacell Corporation, a Delaware corporation (the “Company”) and the Purchasers. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Agreement.
